Vertex Pharmaceuticals Inc | Business Contracts

Vertex Pharmaceuticals Employee Compensation Plan (Filed With SEC on February 10, 2023)

Description of Securities (Filed With SEC on February 10, 2023)

Amendment No. 7 to Research, Development and Commercialization Agreement, dated October 13, 2016, between Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation... (Filed With SEC on November 3, 2021)

Lease, dated May 5, 2011, between Fifty Northern Avenue LLC and Vertex Pharmaceuticals Incorporated (Filed With SEC on July 30, 2021)

Form of Restricted Stock Unit Agreement Under 2013 Stock and Option Plan (Filed With SEC on February 13, 2020)

Agreement and Plan of Merger, dated as of August 30, 2019, by and among Vertex Pharmaceuticals Incorporated, Vertex Disc Inc., Semma Therapeutics, Inc., and Shareholder... (Filed With SEC on October 31, 2019)

Amendment No. 2 to Employment Agreement, between Jeffrey M. Leiden and Vertex Pharmaceuticals Incorporated, dated as of February (Filed With SEC on February 10, 2023)

Vertex Pharmaceuticals Non-Employee Board Compensation (Filed With SEC on February 9, 2022)

Change of Control Agreement, dated August 1, 2020, by and between Vertex Pharmaceuticals Incorporated and Nia Tatsis (Filed With SEC on February 9, 2022)

Employment Agreement, dated August 1, 2020, by and between Vertex Pharmaceuticals Incorporated and Nia Tatsis (Filed With SEC on February 9, 2022)

Amendment No. 1 to Employment Agreement, between Jeffrey M. Leiden and Vertex (Filed With SEC on February 9, 2022)

Amendment No. 5 to Research, Development and Commercialization Agreement, effective as of April 1, 2011, between Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation... (Filed With SEC on November 3, 2021)

Amendment No. 1 to Research, Development and Commercialization Agreement, dated as of January 6, 2006, between Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation... (Filed With SEC on November 3, 2021)

Research, Development and Commercialization Agreement, dated as of May 24, 2004, between Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation Therapeutics... (Filed With SEC on November 3, 2021)

Lease, dated May 5, 2011, between Eleven Fan Pier Boulevard LLC and Vertex Pharmaceuticals Incorporated (Filed With SEC on July 30, 2021)

Amended and Restated Joint Development and Commercialization Agreement, dated April 16, 2021, between Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited... (Filed With SEC on July 30, 2021)

Joint Development and Commercialization Agreement, dated December 12, 2017, between Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited and CRISPR... (Filed With SEC on February 11, 2021)

Employment Agreement, dated as of April 1, 2020, between Vertex Pharmaceuticals Incorporated and Dr. Jeffrey M. Leiden (Filed With SEC on April 1, 2020)

Amended and Restated Change of Control Agreement, dated as of May 18, 2012, between Vertex Pharmaceuticals Incorporated and Paul M. Silva (Filed With SEC on February 13, 2020)

Description of Securities (Filed With SEC on February 13, 2020)

Agreement and Plan of Merger, dated as of June 6, 2019, among Vertex Pharmaceuticals Incorporated, VXP Merger Sub, Inc., Exonics Therapeutics, Inc. and Shareholder Representative... (Filed With SEC on August 1, 2019)

Amendment No. 1, dated as of July 24, 2019, to the Amended and Restated Employment Agreement, dated November 30, 2016, by and between Vertex Pharmaceuticals Incorporated and... (Filed With SEC on July 25, 2019)

Change of Control Agreement, dated as of July 24, 2019, between Vertex Pharmaceuticals Incorporated and Reshma Kewalramani (Filed With SEC on July 25, 2019)

Employment Agreement, dated as of July 24, 2019, between Vertex Pharmaceuticals Incorporated and Reshma Kewalramani (Filed With SEC on July 25, 2019)

Employment Agreement, dated March 28, 2019, by and between Vertex Pharmaceuticals Incorporated and Charles F. Wagner, Jr (Filed With SEC on May 1, 2019)

Change of Control Agreement, dated as of March 28, 2019, by and between Vertex Pharmaceuticals Incorporated and Charles F. Wagner, Jr (Filed With SEC on May 1, 2019)

Vertex Pharmaceuticals Non-Employee Board Compensation (Filed With SEC on February 13, 2019)

Vertex Pharmaceuticals Inc (27)